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Microbes and rosacea 
Rosacea is a common dermatological condition that predominantly affects the 
central regions of the face. Rosacea affects up to 3% of the world’s population and 
a number of subtypes are recognized. Rosacea can be treated with a variety of 
antibiotics (e.g. tetracycline or metronidazole) yet no role for bacteria or microbes 
in its aetiology has been conclusively established. The density of Demodex mites 
in the skin of rosacea patients is higher than in controls, suggesting a possible 
role for these mites in the induction of this condition. In addition, Bacillus 
oleronius, known to be sensitive to the antibiotics used to treat rosacea, has been 
isolated from a Demodex mite from a patient with papulopustular rosacea and a 
potential role for this bacterium in the induction of rosacea has been proposed. 
Staphylococcus epidermidis has been isolated predominantly from the pustules of 
rosacea patients but not from unaffected skin and may be transported around 
the face by Demodex mites. These findings raise the possibility that rosacea is 
fundamentally a bacterial disease resulting from the over proliferation of Demodex 
mites living in skin damaged as a result of adverse weathering, age or the 
production of sebum with an altered fatty acid content. This review surveys the 
literature relating to the role of Demodex mites and their associated bacteria in 
the induction and persistence of rosacea and highlights possible therapeutic 
options. 
Rosacea: definition and epidemiology 
Rosacea is a common chronic inflammatory dermatosis of the face that affects up to 3% of the 
world’s population (Buechner, 2005). Skin lesions are usually located in the central regions of the 
face, involving mostly the cheeks, nose and chin. Occasionally, lesions may be found on sun-
exposed areas such as the neckline, the neck and ears; however, the periocular region often remains 
lesion-free (Powell, 2005). The rash is usually symmetrical and may be described according to 
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associated or underlying symptoms of vascular origin (flushing or permanent erythema, 
telangiectasias or oedema), as well as the presence of papules and pustules, which can develop 
secondarily. In some patients, hypertrophy of connective tissue and hyperplasia of the sebaceous 
glands may occur, resulting in the development of phyma. Rosacea usually affects people between 
the ages of 30 and 50 and is rare in children. Rosacea affects mostly fair-skinned people with 
Fitzpatrick skin phototypes I and II (Del Rosso, 2006) and is three times more common in women 
than in men (Butterwick et al., 2006). In men, the disease has a more severe course and men with 
rosacea have an increased tendency to develop phyma lesions (Buechner, 2005). The standard 
classification system for rosacea identified four basic stages of the disease: erythematotelangiectatic 
rosacea (ETR) (Fig. 1), papulopustular rosacea (PPR) (Fig. 2), phymatous rosacea, ocular rosacea 
(Fig. 3) and one variant rosacea, granulomatous rosacea (GR) (Wilkin et al., 2002). 
Diagnostic criteria of rosacea include primary features, such as flushing erythema, permanent 
erythema, papules, pustules and telangiectasias, the presence of which on the convexities of the face 
justifies the diagnosis of rosacea, and secondary features, such as the feeling of burning or tingling 
of the skin, oedema, the presence of tarsus, dryness of the skin, ocular symptoms, lesions outside 
the face and hyperplastic changes, which aid the diagnostic process (Wilkin et al., 2002) 
Etiopathogenesis 
The etiopathogenesis of rosacea remains unexplained, as the pathogenic mechanisms that lead to the 
development of the skin lesions have not yet been fully elucidated. Possible factors responsible for 
rosacea may include autoimmune dysregulation, vascular disorders, external factors, degeneration 
of connective tissue elements, functional disorders of the pilosebaceous unit, nutritional and 
chemical factors and infectious factors (Crawford et al., 2004, Yamasaki & Gallo, 2009). Over a 
significant period of time, there have been numerous attempts to connect the etiopathogenesis of 
rosacea with the presence of some micro-organisms on or within the skin (Lazaridou et al., 2011), 
including Demodex mites and bacteria. It is well established that there is a higher density of 
Demodex mites in the skin of rosacea patients than control patients but the significance of this has 
been disputed (Vance, 1986; Bonnar et al., 1993; Erbağci & Ozgöztaşi, 1998). This review will 
explore the current understanding of the role of these organisms in the induction of rosacea. 
Demodex folliculorum 
There are more than 100 species of Demodex mites (class Arachnida, subclass Acarina) and all are 
highly specialized, host-specific obligatory commensals of mammals. Various kinds of Demodex 
mites may infest the skin of the host, depending on the preferred area on the skin (Lacey et al., 
2009). In many cases, mite infestation is asymptomatic and their role remains unclear (Lacey et al., 
2011). The pathogenic role of Demodex mites is well-documented in dogs where Demodex canis 
causes demodicosis – a serious, potentially fatal disease connected with numerous skin and ocular 
symptoms (Gortel, 2006). 
Human skin may be inhabited by two species of Demodex mites and both have a worm-like shape 
and are covered by a thin cuticle (Fig. 4). The larger species, Demodex folliculorum, is about 0.3–
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0.4 mm long, has an elongated shape and resides in hair follicles in a cluster consisting of several 
mites. The smaller species, Demodex brevis, is about 0.2–0.3 mm long, has a spindle shape, shorter 
legs and resides solitarily in the sebaceous or meibomian glands (Raszeja-Kotelba et al., 2004). As 
D. brevis inhabits the deep parts of the skin, it is difficult to extract it without tearing of tissue. Due 
to the fact that the main food sources for mites in all phases of the development are epidermal cells 
and sebum components, they reside in skin areas particularly rich in sebaceous glands, such as the 
face – especially the nose, cheeks, forehead and chin. They may also be found in the external 
auditory canal, on the chest and in the genital area (Raszeja-Kotelba et al., 2004). 
The ultrastructure of Demodex mites 
The gnathosoma, comprising the mouth and feeding parts, is located in the anterior portion of the 
Demodex body, the rest of the body consists of prosoma and opisthosoma (Fig. 4). The gnathosoma 
of D. folliculorum has sharp, stylet-like chelicerae, more developed than those of D. brevis, which 
are used to cut and take food, and pedipalps, which are used to hold the food. Both species have 
four pairs of legs in the prosoma (Jing et al., 2005). Demodex mites use the chelicerae to cut the 
epithelial cells of the host skin, secrete lytic enzymes for pre-oral digestion and evacuate liquid 
cytoplasm components (Desch & Nutting, 1972). In the process of destroying the epithelial cells, 
the epithelial barrier is often disturbed and the mite penetrates into the dermis stimulating Toll-like 
receptors (TLR) (Schauber et al., 2007). Proteolytic enzymes (proteases) are among the digestive 
enzymes secreted by Demodex mites. Concrements of serum immunoglobulin IgD and two 
inhibitors of serum proteases (α-1-antitrypsin and α-1-antichymotrypsin), which might be a specific 
defensive reaction of the host against mites, have been detected on the surface of Demodex mites 
(Tsutsumi, 2004). In atopic dermatitis, proteases produced by house dust mites have been identified 
as the factor responsible for local skin irritation (Deleuran et al., 1998). 
Demodex life cycle 
In all phases of their life cycle, Demodex mites avoid sunlight. They emerge from the pilosebaceous 
units at night and migrate across the surface of the skin to find a mating partner, travelling at a 
speed of about 16 mm h−1 (Lacey et al., 2011). The life cycle of Demodex mites consists of five 
phases of development and lasts from 14 to 18 days. The copulation takes place near the entry of 
the hair follicle. Afterwards, the gravid female moves to the inside of the sebaceous gland, where 
she deposits eggs, from which the larvae will emerge about 60 h later. Protonymphs and nymphs are 
the next phases of the Demodex life cycle (Lacey et al., 2009; Spickett, 1961) 
Due to the fact that Demodex mites are obligate parasites of the pilosebaceous units and highly 
susceptible to desiccation, they are not capable of surviving for long periods outside the host. 
Routes of transmission are not fully known but it may occur by direct contact as well as through 
dust. While the skin of new-borns is free of Demodex folliculorum, colonization of the skin in 
humans takes place in childhood or early adulthood. Demodex mites are found in representatives of 
all human races and in all geographical areas (Lacey et al., 2009). 
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Role of Demodex mites in human skin disease 
Demodex mites were originally perceived to be commensals, having a symbiotic relationship with 
the human host. However the opinion about the role of Demodex in pathogenesis of many diseases, 
including rosacea has been changing (Lacey et al., 2009). In some specific conditions in the host 
system, Demodex mites may become potential pathogens. This may happen when the 
immunological conditions of the host change and new environmental conditions on the skin 
facilitate the development of Demodex mites (Dahl et al., 2004; Whitfeld et al., 2011). 
There are certain differences in distribution on the skin between the two species of Demodex mites 
found in the human population. D. folliculorum counts are notably higher but D. brevis inhabits a 
larger area of the human body. The proportion of D. brevis to D. folliculorum also differs among 
men (1:4, respectively) and women (1:10) (Bohdanowicz & Raszeja-Kotelba, 2001). D. 
folliculorum is more often associated with erythema and epithelial desquamation, whereas D. brevis 
is linked with papulopustular eruption, symmetrical rashes and conditions arising on the 
background of a pre-existing disease (Akilov et al., 2005). 
The extent of Demodex colonization in the human population is high (20–80%), reaching 100% in 
elderly people (Elston, 2010). Mite density starts to rise in the sixth decade of life and stays at the 
same level until the eight decade of life. Mite density is very low in young adults, even though their 
levels of sebum production, a potential source of food for mites, are very high (Ozdemir et al., 
2005; Aylesworth & Vance, 1982). Patients with papulopustular rosacea produce sebum with an 
altered fatty acid profile, suggesting that the nature of the sebum, rather than its quantity, may 
favour the development of Demodex mites (Ní Raghallaigh et al., 2012). This finding raises the 
possibility that non-antibiotic therapies to restore the normal fatty acid composition of sebum may 
improve skin integrity and inhibit the proliferation of Demodex mites. 
Due to the fact that Demodex mites are commonly found in healthy individuals and the density of 
mites is generally low, the presence of mites on the skin is not enough to determine pathogenicity. 
An increase in mite density on facial skin is observed in perioral dermatitis, caused by long-term 
use of local steroids or other immunomodulating drugs (Fujiwara et al., 2010). Higher numbers of 
Demodex mites have been noted in patients undergoing immunosuppressive therapy, for example 
children receiving chemotherapy for leukaemia (Ivy et al., 1995), patients with HIV-infection or 
AIDS (Aquilina et al., 2002; Dominey et al., 1989) and chronic dialysis patients (Karincaoglu et al., 
2005). 
A positive correlation between high density of Demodex mites and the presence of antigens 
affecting tissue compatibility, HLA Cw2 and Cw4, has been established (Akilov & Mumcuoglu, 
2003). Furthermore, increased numbers of mites have been associated with a higher tendency of 
leukocytes to undergo apoptosis. Such a genetically conditioned decreased immune performance 
may result in local immuno-suppression and so facilitate survival and replication of Demodex mites 
(Akilov & Mumcuoglu, 2004). 
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Ayres & Anderson (1932) first suggested a correlation between the presence of Demodex mites on 
the skin and development of various skin lesions (Ayres, 1930). They described a disease entity 
which they named ‘pityriasis folliculorum’ and associated its development with the presence of D. 
folliculorum mites. Pityriasis folliculorum is characterized by small, follicular, scaling papules, the 
feeling of skin dryness and pruritus. Lesions in pityriasis folliculorum are usually unilateral, located 
mainly on the cheeks, but may also reach the eyelids (Ayres, 1930). Ayres & Ayres, (1961) 
identified a new disease entity, rosacea-like demodicosis, caused by the presence of abundant D. 
folliculorum mites and characterized by erythema, dryness and fine follicular scaling. Later research 
proved pityriasis folliculorum to be a form of demodicosis, and the most frequent one (54%), but so 
discrete and unfamiliar that it was often not diagnosed. Demodicosis is characterized by discrete 
symptoms of erythema, higher densities of Demodex mites per cm2 (up to 61 mites per cm2) in 
comparison to papulopustular rosacea (up to 36 mites per cm2), and is primarily a disease of the 
elderly or immunocompromised. A compromised immune system is thought to enable such 
proliferation of Demodex mites in cases of pityriasis folliculorum (Forton et al., 2005). 
The mean density of Demodex mites on the skin of rosacea patients is 10.8 mites per cm2 in 
comparison to 0.7 mites per cm2 in healthy people. However, when all types of rosacea are taken 
into account, statistically larger mite densities per cm2 are found in cases of papulopustular rosacea 
(Forton & Seys, 1993). Other diseases in which infestation with Demodex mites is believed to be 
the aetiological factor include blepharitis (Czepita et al., 2007) and, in one case, hair loss described 
in a 6-year-old boy (García-Vargas et al., 2007). 
Histopathological examination of skin specimens obtained from control patients revealed the 
presence of Demodex mites in 10% of all facial skin biopsies and in 12% of all pilosebaceous units 
(Aylesworth & Vance, 1982). Skin specimens with histological features of folliculitis revealed that 
D. folliculorum mites were found in 42% of inflamed and only 10% of non-inflamed follicles. 
Overall, 83% of all affected follicles demonstrated features of inflammation. However, whether D. 
folliculorum causes folliculitis or simply inhabits inflamed follicles remains unclear (Vollmer, 
1996). In a study conducted in patients with papulopustular rosacea, the presence of D. folliculorum 
in follicle secretions was found in 90.2% of patients and only 11.9% of control samples. 
Additionally, histopathological examination of skin obtained from these patients revealed that the 
presence of Demodex mites was connected with severe perifollicular lymphocytary infiltration 
(Georgala et al., 2001). 
It seems that the presence of Demodex mites within the skin is more important than their presence 
on the skin and dermal symptoms occur when mites residing in hair follicles penetrate into the 
surrounding tissues (Ayres & Ayres, 1961). Most probably, when Demodex mites breach the 
epithelial barrier, their antigens influence the immune system of the host and induce a type IV 
hypersensitivity reaction. Demodex mites may then be attacked by giant cells giving rise to dermal 
granulomas, which are most often observed in granulomatous acne rosacea. Granulomas are also 
found in skin biopsies of patients with papulopustular rosacea and even in patients with 
erythematous rosacea (Hsu et al., 2009). 
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The causal relationship of Demodex mites in skin lesions has been suspected to occur through 
several mechanisms. They may mechanically block the follicles, leading to distension and causing 
intra-follicular hyperkeratosis. The presence of mite’s chitinous external skeleton may act like a 
foreign body and contribute to the formation of granulomas. The waste products of Demodex mites 
and/or associated bacteria may activate the elements of innate immune system or stimulate the 
immune system through the mechanism of delayed hypersensitivity reaction (Bevins & Liu, 2007). 
Potential role of Bacillus oleronius in rosacea 
One hypothesis concerning the role of Demodex mites in the induction of rosacea assumes that 
Demodex are vectors for micro-organisms that causes and exacerbates skin lesions (Hsu et al., 
2009). The theory has its roots in the fact that clinical improvement was noted in patients with 
rosacea who were administered tetracycline antibiotics, although these antibiotics neither 
demonstrate activity against D. folliculorum nor reduce their numbers on the skin. It has been 
suggested that the beneficial activity of antibiotics was due to their anti-inflammatory properties; 
however, other anti-inflammatory agents, such as steroids or tacrolimus, intensify the symptoms of 
rosacea or even induce its development (Antille et al., 2004). The fact that only some drugs proved 
to be effective in the treatment of rosacea suggested that that an unknown bacterium may have a 
role in the pathogenesis of the disease. Attempts to prove the presence of DNA of Gram-negative 
intracellular bacterium Wolbachia pipientis, which has been detected in various species of mites and 
nematodes, proved futile in the case of Demodex mites (Borgo et al., 2009). Bacillus oleronius was 
isolated from a Demodex mite, obtained from a patient with papulopustular rosacea (Lacey et al., 
2007). The species is an endosporic Gram-negative bacterium (genus Bacillus, family Bacillaceae) 
and was first described in 1995 when it was isolated from the hindgut of the termite Reticulitermes 
santonensis, where it most likely plays a symbiotic role (Kuhnigk et al., 1995). The bacterium 
produces proteins capable of stimulating peripheral blood mononuclear cell proliferation in 16 out 
of 22 (73%) patients with papulopustular rosacea compared to only 5 out of 17 (29%) in control 
patients. The sera of six other patients with papulopustular rosacea reacted with two antigens 
isolated from the bacterium: two specific proteins of 62 kDa and 83 kDa, bearing similarity to the 
heat-shock proteins) (Lacey et al., 2007). Another experiment investigated sera from 59 patients 
with diagnosed rosacea and a statistically significant correlation was demonstrated between positive 
reactions of the serum from these patients with B. oleronius antigens and the presence of Demodex 
mites on their eyelashes and facial skin lesions (Li et al., 2010). Recent work has indicated that a 
range of B. oleronius proteins can activate neutrophils which migrate and produce inflammatory 
cytokines. It was speculated that the release of B. oleronius from dead Demodex mites within the 
pilosebaceous unit could lead to the release of a range of Bacillus proteins into the unit, which 
‘leak’ into the surrounding tissue and so attract neutrophils (O’Reilly et al., 2012). If this occurs in 
vivo it would lead to inflammation and tissue degradation in the vicinity of the pilosebaceous unit. 
Interestingly, inflammation in papulopustular rosacea is often orientated around the pilosebaceous 
unit, suggesting that the focus of the inflammation is within or adjacent to the unit (Lacey et al., 
2007). Exposure of corneal epithelial cells to Bacillus proteins results in an aberrant wound healing 
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response, suggesting a possible link between the action of these antigens on the corneal surface and 
the development of sterile ulcers which are a common feature of ocular rosacea (O’Reilly et al., 
2012). 
Recent examination of patients with blepharitis has provided further evidence on the pathogenic 
role of B. oleronius (Szkaradkiewicz et al., 2011). The severity of the disease did not correspond 
with an increased number of Demodex mites per lash, with the exception of the five most severe 
cases, where a greater numbers of mites were observed. Statistically significant differences in B. 
oleronius incidence rates were found between patients with severe disease and healthy controls. 
This might indicate that Demodex mites constitute an independent pathogenic factor of blepharitis 
and the B. oleronius bacteria, carried by the mites, most probably play a role as a co-pathogen in the 
development of more severe forms of blepharitis. 
Role of Staphylococcus epidermidis in rosacea 
Staphylococcus epidermidis has been isolated from the pustules of 9 out of 15 patients with 
papulopustular rosacea, whereas this bacterium was not detected on unaffected areas of the skin 
(Whitfeld et al., 2011). S. epidermidis was also isolated from the eyelid margins of 4 out of 15 
patients with papulopustular rosacea, whereas no pure growth was isolated from the eyelids of age- 
and sex-matched control subjects. The same study also found that this bacterium was susceptible to 
antibiotics commonly used to treat rosacea. Facial erythema and increased blood flow in the skin of 
those with rosacea causes the temperature of the skin to become elevated. Dahl et al. (2004) found 
that S. epidermidis secreted more proteins when cultured at 37 °C than at 30 °C and that isolates 
from rosacea patients’ skin were consistently β-haemolytic, whereas isolates from control subjects 
were non-haemolytic. Demodex mites have been shown to transport bacteria around the face (Lacey 
et al., 2007) so the possibility remains that S. epidermidis, along with other bacteria, are moved to 
areas which favour their proliferation. 
Conclusion 
Rosacea is a complex disease entity of disputed aetiology. The literature offers numerous arguments 
supportive of the theory that rosacea is primarily connected with compromised immunity (Forton, 
2012). According to this theory, on the skin of healthy, immune-competent individuals, the 
proliferation of Demodex mites is kept under control. In the first stage of rosacea, studied by 
investigators of the clinical form of pityriasis folliculorum, no inflammation is observed, despite the 
presence of a large number of Demodex mites. This is probably caused by an unidentified, genetic 
defect of the innate immunity (Akilov & Mumcuoglu, 2003) and/or the localized 
immunosuppressive influence of the mites (Akilov & Mumcuoglu, 2004). In the later stages of the 
disease, characterized by developed rosacea, there is an overstimulated reaction of the immune 
system, which includes elevated levels of serine proteases, kallikrein (KLK5), the presence of 
abnormal forms of cathelicidins (with lower anti-bacterial potential) (Yamasaki et al., 2007; 
Schauber & Gallo, 2008) and increased expression of Toll-like 2 receptors (TLR 2), which 
stimulate the calcium-dependent production of kallikrein (Yamasaki et al., 2011). 
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Such immunological conditions favour the development of different types of micro-organisms, 
including Demodex mites. Other characteristic features of rosacea patients, such as increased 
vascularization and elevated temperature, may further promote the growth of the organisms 
(Whitfeld et al., 2011). Developing Demodex mites may be causative agents of rosacea through 
various mechanisms: they may mechanically block hair follicles, secrete digestive enzymes, destroy 
the epithelial barrier or trigger reactions of the immune system.  
It is believed that B. oleronius forms a symbiotic relationship with Demodex, as it does in the 
termite (Kuhnigk et al., 1995). On the skin of humans, this bacterium may occur in the endospore 
form, which enters the digestive tract of Demodex mites when they consume epithelial cells. The 
dead mites then decompose inside the hair follicles, where they release significant numbers of 
bacterial antigens, which have the potential to stimulate a strong immune response (O’Reilly et al., 
2012). Thus, the intensification of blepharitis and rosacea, especially the papulopustular variant, 
may not be induced so much by the presence of the mites alone but by the presence of Demodex 
mites that carry B. oleronius in their digestive tract. Empirically confirmed sensitivity of B. 
oleronius to different antibiotics, especially doxycycline, (Lacey et al., 2007) might explain the 
favourable therapeutic effect of the drug in diseases such as rosacea and blepharitis. 
The pathogenic role of Demodex mites, as well as B. oleronius and S. epidermidis, in the induction 
and persistence of rosacea remains an unresolved issue. The lack of an immunological response to 
Demodex mites in healthy skin raises the possibility of localized immunosuppression, facilitating 
the survival of the mite. Hopefully, the results of further research will bring us closer to 
understanding the role of microbes in the pathogenesis of rosacea and assist in the development of 
new and more effective therapies for the treatment of this disfiguring disease. 
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Fig. 1. Erythematotelangiectatic 
rosacea. Note presence of 
inflammation on skin and increased 
vascularization on nose. 
 
 
Fig. 2. Papulopustular rosacea. 
Characteristics papules and pustules 
are present on skin of cheek. 
 
 
 
Fig. 3. Ocular rosacea. Note 
inflammation on eyelid margins. 
 
 
Fig. 4. Demodex folliculorum mite embedded in a hair 
follicle. The body parts of the mite, including the head–
neck segment (a), the body–tail segment (b), the four 
pairs of short legs attached to the head–neck (c) and the 
mouth parts (d), are shown. Length, 0.4 mm. 
 
